---
schema_version: "secwatch.filing_event.v1"
accession: "0000075252-23-000042"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T06:40:31.076098+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor Q2 net loss $0.37/share; revenue up 2.5% to $2.56B; adjusted EPS $0.18

## Summary
- GAAP net loss per share $(0.37) vs prior year $0.37; adjusted EPS $0.18 vs $0.76.
- Revenue $2.56B, up 2.5% YoY; Patient Direct segment double-digit growth drove top line.
- Operating cash flow $313M including $115M receivables sales; net debt reduced $269M.
- Products & Healthcare Services segment saw Global Products headwinds; management cautious on H2 2023.

## SEC filing metadata
- accession: 0000075252-23-000042
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/0000075252-23-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/omi-20230804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000075252-23-000042
- JSON: https://secwatch.observer/filing/0000075252-23-000042.json
- Plain text: https://secwatch.observer/filing/0000075252-23-000042.txt

## Key facts
- Earnings Releases
  ACCENDRA HEALTH INC/VA/ reported six months ended June 30, 2023 results: revenue $5,086, net income $(52.7), EPS $(0.70).
  - Period: six months ended June 30, 2023
  - Revenue: $5,086
  - Net income: $(52.7)
  - EPS: $(0.70)
  - Result: reported results
  source text: Financial Summary (1) YTD YTD ($ in millions, except per share data) 2Q23 2Q22 2023 2022 Revenue $2,563 $2,500 $5,086 $4,907 Operating income, GAAP $10.8 $75.1 $20.6 $136.1 Adj. Operating Income, Non-GAAP $62.0 $113.6 $109.7 $218.5 Net (loss) income, GAAP $(28.2) $28.6 $(52.7) $67.9 Adj. Net Income, Non-GAAP $14.2 $58.3 $17.8 $131.0 Adj. EBITDA, Non-GAAP $112.8 $163.4 $221.5 $285.9 Net (loss) income per common share, GAAP $(0.37) $0.37 $(0.70) $0.89 Adj. Net Income per share, Non-GAAP $0.18 $0.76 $0.23 $1.72
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/0000075252-23-000042-index.htm
- Earnings Releases
  ACCENDRA HEALTH INC/VA/ reported second quarter ended June 30, 2023 results: revenue $2.56 billion, net income $(0.37) per common share, EPS $(0.37) per common share.
  - Period: second quarter ended June 30, 2023
  - Revenue: $2.56 billion
  - Net income: $(0.37) per common share
  - EPS: $(0.37) per common share
  - Result: reported results
  source text: Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: • Consolidated revenue of $2.56 billion • Net loss per common share of $(0.37) and adjusted net income per common share of $0.18
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/0000075252-23-000042-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.